REFERENCES
1. Menko FH, Maher ER, Schmidt LS, et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. Fam Cancer 2014;13(4):637-+644.
2. Muller M, Ferlicot S, Guillaud-Bataille M, et al. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet 2017;92(6):606-615.
3. Forde C, Lim DHK, Alwan Y, et al. Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals. Eur Urol Oncol 2019.
4. Nix J, Shuch B, Chen V, et al. 2008 Clinical features and management of hereditary leiomyomatosis and renal cell cancer (HLRCC). J Urol 2012;187(4S):e810-e810.
5. Taniguchi R, Muramatsu H, Okuno Y, et al. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement. Pediatr Blood Cancer 2018;65(2).
6. Park I, Shim YS, Go H, Hong BS, Lee JL. Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures. BMC Urol 2019;19(1):51.
7. Pollard PJ, Spencer-Dene B, Shukla D, et al. Targeted inactivation of FH1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 2007;11(4):311-319.
8. Terada N, Ichioka K, Matsuta Y, Okubo K, Yoshimura K, Arai Y. The natural history of simple renal cysts. J Urol 2002;167(1):21-23.
9. Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK, et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 2006;43(6):523-526.
10. Ristau BT, Kamat SN, Tarin TV. Abnormal cystic tumor in a patient with hereditary leiomyomatosis and renal cell cancer syndrome: evidence of a precursor lesion? Case Rep Urol 2015;2015:303872.
11. Hol JA, Jongmans MCJ, Littooij AS, et al. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature. Fam Cancer 2020;19(1):55-63.